Aviva to sell majority shareholding in Singapore

RNS Number : 7947Y
Aviva PLC
11 September 2020
 

 

This announcement contains inside information

 

11 September 2020

 

Aviva to sell majority shareholding in Aviva Singapore*

 

 

In line with the recently announced strategy, Aviva plc ("Aviva") has agreed to sell a majority shareholding in Aviva Singapore to a consortium led by Singapore Life Ltd ("Singlife") to support the creation of one of the country's leading insurance companies. The combination brings together Aviva Singapore's scale and leading franchise with Singlife's innovative and digitally focused capabilities. In Singapore, the new business will be initially branded as Aviva Singlife.

 

The Singlife consortium includes TPG, a leading global alternative asset firm, which will become the largest shareholder in the new group upon completion, Sumitomo Life, a leading Japanese insurer, and other existing Singlife shareholders.

 

On completion, Aviva will receive SGD 2.7 billion (£1.6 billion) in consideration, which is comprised of SGD 2.0 billion (£1.2 billion) in cash and marketable securities1, SGD 250 million in vendor finance notes and a 25% equity shareholding in the new group. The transaction represents a multiple of 18.7x Aviva Singapore's 2019 IFRS profit after tax, 2.0x Solvency II Own Funds at 30 June 2020 and 1.9x Net Asset Value at 30 June 2020.

 

The transaction would have increased Aviva plc's Net Asset Value at 30 June 2020 by £0.7 billion2, strengthened Solvency II capital surplus by £0.5 billion and increased the Group Solvency ratio on a shareholder basis by approximately 4 percentage points. In 2019, Aviva Singapore's IFRS profit after tax was £83 million and it remitted £46 million cash to the group. The gross assets of Aviva Singapore were £6.6 billion at 30 June 2020.

 

Customers and partners of Aviva Singapore will continue to deal with Aviva as usual and there is no impact to customer policies as a result of this announcement3. Aviva Investors' operations and clients in Asia will not be impacted by this transaction.

 

The proceeds will be used to further strengthen Aviva's central liquidity and will be considered as part of Aviva's broader capital management and debt reduction objectives.

 

The transaction is subject to customary closing conditions, including regulatory approval, and is expected to complete by January 2021.

 

Amanda Blanc, Group Chief Executive Officer of Aviva, said:

 

"The sale of Aviva Singapore is a significant first step in our new strategy to bring greater focus to Aviva's portfolio. We have achieved excellent upfront value for shareholders but have also retained an investment in a leading Singapore life business with attractive long term growth potential. The proceeds from the sale will further strengthen our financial position and enhance our ability to meet our strategic objectives.

 

We continue to work at pace and are seeking to take decisive action on our portfolio with the goal of further enhancing long term value for our shareholders."  

 

*This announcement contains inside information. The person responsible for making this announcement on behalf of the Group is Kirstine Cooper (Group Company Secretary).

 

-ends-

 

Enquiries :

 

Media:

 

Andrew Reid  +44 (0)7800 694 276

Sarah Swailes  +44 (0)7800 694 859

 

Analysts :

 

Chris Esson  +44 (0)20 7662 8115

Diane Michelberger                                                                                           +44 (0)20 7662 0911

 

 

Notes to editors :

1.  Comprising SGD1.7bn of cash , SGD80m pre completion dividend and a SGD260m debt capital instrument underwritten by Aviva on market terms with the intention to sell to external investors in due course.

2.  Consideration translated into GBP at 30 June spot rate of 1.72.

3.  The current Aviva Singapore CEO Nishit Majmudar will be appointed as CEO of the combined entity's Singapore licensed business. 

· For information on how Aviva is helping our people, customers and communities impacted by COVID-19 visit: www.aviva.com/covid-19-our-response/  

· Aviva is a leading international savings, retirement and insurance business. We exist to be with people when it really matters, throughout their lives - to help them make the most of life. We have been taking care of people for more than 320 years, in line with our purpose of being 'with you today, for a better tomorrow'.

· Our vision is to earn our customers' trust as the best place to save for the future, navigate retirement and insure what matters most to them. In 2019, we paid £33.2 billion in claims and benefits on behalf of our 33.4 million customers.

· We will focus on the UK, Ireland and Canada where we have leading market positions and significant potential. We will invest for growth in these markets. Our International businesses in Europe and Asia will be managed for long-term shareholder value. We will also transform our performance and improve our efficiency. Our transformation will be underpinned by managing our balance sheet prudently, reducing debt and increasing our financial resilience.

· Total group assets under management at Aviva group are £522 billion and our Solvency II capital surplus is £12.0 billion (HY20). Our shares are listed on the London Stock Exchange and we are a member of the FTSE 100 index.

· For more details on what we do, our business and how we help our customers, visit www.aviva.com/about-us  

· The Aviva newsroom at www.aviva.com/newsroom includes links to our image library, research reports and our news release archive. Sign up to get the latest news from Aviva by email.

· You can follow us on Twitter: www.twitter.com/avivaplc/  

· You can follow us on LinkedIn: www.linkedin.com/company/aviva-plc  

· For the latest corporate films from around our business, subscribe to our YouTube channel: www.youtube.com/user/aviva  

· We have a Globelynx system for broadcast interviews. Please contact the Press Officer noted above if you would like to make a booking.  

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DISFZGMLFMLGGZM

Companies

Aviva (AV.)
UK 100

Latest directors dealings